Bleeding peptic ulcer - time trends in incidence, treatment and mortality in Sweden

Aliment Pharmacol Ther. 2009 Aug 15;30(4):392-8. doi: 10.1111/j.1365-2036.2009.04058.x. Epub 2009 Jun 6.

Abstract

Background: The incidence of peptic ulcer disease was expected to decrease following the introduction of acid inhibitors and Helicobacter pylori eradication.

Aim: To analyse possible changes in the incidence of bleeding peptic ulcer, treatment and mortality over time.

Methods: Residents of Malmö hospitalized for bleeding gastric or duodenal ulcer disease during 1987-2004 were identified in hospital databases (n = 1610). The material was divided into 6-year periods to identify changes over time. All patients who had been submitted to emergency surgery (n = 137) were reviewed.

Results: The incidence rate for bleeding gastric or duodenal ulcers decreased by one half in males and by one-third in females and emergency operations decreased significantly (9.2%, 7.5% and 5.7% during the three time periods, respectively (P < 0.05). The post-operative mortality tended to decrease (9.7, 2.4 and 3.7%, respectively) and the 30-day mortality rates in the whole material were 1.2%, 3.6% and 3.4% during the different time periods.

Conclusion: The incidence of bleeding gastric and duodenal ulcer disease has decreased markedly. Operative treatment has been replaced by endoscopic treatment. The bleeding ulcer-related mortality was less than 4% and has not changed over time.

MeSH terms

  • Adult
  • Age Distribution
  • Aged
  • Aged, 80 and over
  • Anti-Ulcer Agents / therapeutic use*
  • Cohort Studies
  • Female
  • Helicobacter Infections / complications
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori / isolation & purification*
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Peptic Ulcer / epidemiology*
  • Peptic Ulcer / mortality
  • Peptic Ulcer / therapy
  • Peptic Ulcer Hemorrhage / epidemiology*
  • Peptic Ulcer Hemorrhage / mortality
  • Peptic Ulcer Hemorrhage / therapy
  • Risk Factors
  • Sex Distribution
  • Sweden / epidemiology
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Ulcer Agents